Walgreens, Instacart Partner to Accept Online Snap/EBT Payments (2024)

WALGREENS BOOTS ALLIANCE, INC.

Add to a list

To use this feature you must be a member

Log inSign up

Equities

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq Other stock markets 04:00:00 2024-08-07 pm EDT			Pre-market 09:27:40 am
10.78 ^USD	-1.19%		10.80	+0.23%

03:17pm	Nasdaq's wild mood swings
Aug. 07	Walgreens explores options for selling VillageMD business	RE

Summary

Quotes

Charts

News

Company

Financials

Latest news about Walgreens Boots Alliance, Inc.

Nasdaq's wild mood swings	09:17am
Walgreens explores options for selling VillageMD business	Aug. 07	RE
Walgreens Mulls Sale of VillageMD	Aug. 07	DJ
Walgreens, Instacart Partner to Accept Online Snap/EBT Payments	Aug. 06	MT
Walgreens Plans to Sell Another Slice of Its Cencora Stake for $1.1 Billion	Aug. 02	CI
Global markets live: Wells Fargo, Nintendo, Apple, Amazon, Alphabet...	Aug. 02
Sector Update: Health Care Stocks Decline Premarket Friday	Aug. 02	MT
Walgreens Boots Alliance Sells Cencora Shares for $1.1 Billion	Aug. 02	MT
Walgreens further reduces stake in Cencora	Aug. 01	RE
Walgreens sells shares in Cencora for about $1.1 billion	Aug. 01	RE
HSBC Adjusts Price Target on Walgreens Boots Alliance to $7 From $11	Jul. 25	MT
GDP High, Nasdaq Sigh	Jul. 25
ANALYST RECOMMENDATIONS : Sirius Xm, Tesla, Chipotle, Spotify, Walgreens Boots...	Jul. 25
Barclays Adjusts Price Target on Walgreens Boots Alliance to $7 From $11	Jul. 22	MT
	Jul. 19	DJ
Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from NASDAQ-100 Index	Jul. 18	CI
	Jul. 15	CI
Walgreens Boots Alliance, Inc. Appoints William H. Shrank to Board of Directors	Jul. 10	CI
Walgreens Boots Alliance Keeps Quarterly Dividend at $0.25 a Share, Payable Sept. 12 to Shareholders of Record Aug. 21	Jul. 10	MT
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024	Jul. 10	CI
Baptista Research Upgrades Walgreens Boots Alliance to Outperform From Hold, Price Target is $13.70	Jul. 09	MT
Top Decliners	Jul. 03	MT
UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating	Jul. 03	MT
Sector Update: Health Care Stocks Softer Late Afternoon	Jul. 02	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	Jul. 02	MT

Chart Walgreens Boots Alliance, Inc.

Duration

Period

More charts

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:- retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;- wholesale distribution (8.1%).The remaining sales (4.7%) are from the healthcareNet sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).

Employees

268,500

Sector

Drug Retailers

Calendar

2024-08-20 - Détachement de

Related indices

More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending March 28, 2024 at 03:59 pm EDT

Walgreens Boots Alliance, Inc. first light at the end of the tunnel? November 27, 2023 at 10:22 am EST

More Strategies

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

10.78USD

Average target price

13.62USD

Spread / Average Target

+26.34%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Stock Market
Equities
WBA Stock
News Walgreens Boots Alliance, Inc.
Walgreens, Instacart Partner to Accept Online Snap/EBT Payments

Protect and grow your investments with the help of our experts Secure my Investments

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '19356230');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });